Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Padma, M. V.
Right arrow Articles by Ahuja, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Padma, M. V.
Right arrow Articles by Ahuja, G. K.
NEUROLOGY 1994;44:1344
© 1994 American Academy of Neurology

Albendazole in single CT ring lesions in epilepsy

M. V. Padma, DM, M. Behari, DM, N. K. Misra, MD and G. K. Ahuja, FRCP

Departments of Neurology (Drs. Padma, Behari, and Ahuja) and Neuroradiology (Dr. Misra), All India Institute of Medical Sciences, New Delhi, India.

Single, small, enhancing lesions that often resolve spontaneously are frequent findings on CTs of Indian patients with seizures. Based on ELISA and biopsy data, the majority of these lesions are probably cysticercosis. To determine if these patients should be treated with albendazole, we performed a double-blind, randomized, placebo-controlled study involving 75 patients with seizures and the appropriate CT abnormality without neurologic abnormality on examination. Patients were randomized to albendazole (15 mg/kg/d) and placebo for 1 week, and we obtained serial CTs at the end of 1 week, 1 month, and 3 months. All patients completed a 3-month follow-up and none had systemic evidence of tuberculosis or cysticercosis. The lesions varied in size from 3 mm to 2.1 cm, with an average size of 1.18 cm. Serum ELISA for cysticercosis was positive in 30 and CSF ELISA was positive in 20 of 45 patients. Forty patients received albendazole and 35 received placebo. At the end of 3 months, a total of 68 patients showed resolution. Thirty-five of 40 patients who received albendazole showed resolution, as opposed to 33 of 35 patients on placebo. We conclude that albendazole therapy was not beneficial.

Address correspondence and reprint requests to Dr. M.V. Padma, Department of Neurology, All India Institute of Medical Sciences, New Delhi-110029, India.

Received November 8, 1993. Accepted in final form January 25, 1994.




This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Carpio, E A Kelvin, E Bagiella, D Leslie, P Leon, H Andrews, W A Hauser, and the Ecuadorian Neurocysticercosis Group
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial
J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1050 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Thussu, A Chattopadhyay, I M S Sawhney, and N Khandelwal
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy
J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 272 - 275.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. E. Nash, G. Singh, A. C. White, V. Rajshekhar, J. A. Loeb, J. V. Proano, O. M. Takayanagui, A. E. Gonzalez, J. A. Butman, C. DeGiorgio, et al.
Treatment of neurocysticercosis: current status and future research needs.
Neurology, October 10, 2006; 67(7): 1120 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
O. H. Del Brutto, K. L. Roos, C. S. Coffey, and H. H. Garcia
Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Ann Intern Med, July 4, 2006; 145(1): 43 - 51.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
P. Singhi and S. Singhi
Topical Review: Neurocysticercosis in Children
J Child Neurol, July 1, 2004; 19(7): 482 - 492.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
P. Singhi, V. Jain, and N. Khandelwal
Corticosteroids Versus Albendazole for Treatment of Single Small Enhancing Computed Tomographic Lesions in Children With Neurocysticercosis
J Child Neurol, May 1, 2004; 19(5): 323 - 327.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
A. P. Wong and M. G. Huss
An Unusual Cause of Seizures After Cardiopulmonary Bypass
Anesth. Analg., April 1, 2003; 96(4): 959 - 961.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Carpio and W. A. Hauser
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis
Neurology, December 10, 2002; 59(11): 1730 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
H. H. Garcia, C. A. W. Evans, T. E. Nash, O. M. Takayanagui, A. C. White Jr., D. Botero, V. Rajshekhar, V. C. W. Tsang, P. M. Schantz, J. C. Allan, et al.
Current Consensus Guidelines for Treatment of Neurocysticercosis
Clin. Microbiol. Rev., October 1, 2002; 15(4): 747 - 756.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. K. Garg, M. K. Katti, and O. H. Del Brutto
Proposed diagnostic criteria for neurocysticercosis
Neurology, April 23, 2002; 58(8): 1315 - 1316.
[Full Text] [PDF]

Home page
 NeurologyHome page
V. Rajshekhar
Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures
Neurology, December 26, 2001; 57(12): 2315 - 2317.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. Carpio, F. Santillan, P. Leon, C. Flores, and W. A. Hauser
Is the Course of Neurocysticercosis Modified by Treatment With Anthelmintic Agents?-Reply
Arch Intern Med, January 13, 1997; 157(1): 129 - 130.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
R. K. Garg and A. Agrawal
Medical Treatment for Cysticercosis
Arch Neurol, April 1, 1996; 53(4): 295 - 295.
[Abstract] [PDF]